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ABSTRACT The intnguing observatton made by Geczy et al (1} showing the possibüity of generating
spectfic ankylosing spondylitis—cytotoxic Τ lymphocytes by presentmg HLA-B27 AS¥ cells as
antigen-speafic stimulator cells prompted us (by ustng Geczy s approach) to identify cytotoxic Ί
lymphocytes specific for this apparent B27+AS+ target structure Penpheral blood mononuclear
cells (PBMC) of 21 healthy B27* indtviduals were stimulated in pnmary and in short-term
cultures wtth PBMC of an HLA identtcal sibling suffenng from definite AS (n = 12) In
addition PBMC in vitro modtfiedby Geczy bactenalproducts from two healthy B27+ individ
uals were used to sttmulate B27*AS lymphocytes (either autologous or from α healthy HLA
identical sibling) Effector cells raised in pnmary AS versus AS+ and AS versus modified
B27 mixed lymphocyte culture combmations showed no prolifetative nor cytotoxic activity at all
The \canely observed cytotoxic reactivity of restimulated mixed lymphocyte culture was not re
stncted to AS B27+ cells These results demonstrate that PBMC from ankylosing spondylitis
patients fall to induce disease specißc cytotoxic Τ lymphocytes and suggest that an ankylosing
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INTRODUCTION
The association of HLA B27 with ankylosing spondyhns (AS) still is one of the
besr exampies of the association between human leukocyte antigens (HLA) and
discase Either thc B27 gcne product ttself or a discase susceptibihty gcne prod
1 uct in tight linkagc disequihbrmm with B27 must account for the observed
association betwccn HLA and diseast So far no evidente favonng onc of thc
lattcr possibilitits has been prescnted
It has bcen reported that antibactenal sera can distinguish lymphocytcs of
B27 AS paticnts from B27 hcalthy blood donors [2—5] These hndings sug
gcsted an interaction of enterte orgamsrns (or their produets) «irh B27 Indcpcn
dent laboratoncs have never sueeeeded in rcproducing these rcsults [6-8] al
though blind Workshops confirmtd fhat celäs from AS paticnts could bc
distinguishcd from control cclls wtth thc Gcczy scra [9-11]
Tbc Jatttr observanon led to thc hypothesis that therc might exist an ahen or
modified strueture on AS B27 cells If so thc qucstion could bc riistd whether
aliogenuc Τ cclls also rccognizc a B27 associated strueture on lymphocytcs of AS
paticnts This possibihty was exammed by Gcczy et al [1] who reported thc
recogninon of an AS associated strueture by cytotoxic Τ lymphocytcs (C1L) In
[wo independent laboratoncs we performed sirmiar expenments wich an identi
cal genctic design In our hands no detcctablc prolifcrative or CTL responses
werc induetd in mixed iymphocytc eultuics (M.LC ) of teils from hcalrhy individ
uals snmuiatcd with ceils from HLA identical Ab paticnts
MA TFR1ALS A N D MLTHODS
Celli Penphcritl blood lymphocytcs (PBL) were isolitcd frorn dciibnnatcd
blood of randomly sclectcd hcalrhy B27 blood donors of dehnitc AS j^dticnts
(aecording to thc New York entena) and of hcalthy B27 sibhngs who were
HLA jdentjeal with the AS proband but did not have evidcncc of sactoihitts
This radiologic sign can bc considered as a condmon sine qua non for thc dia^no
sis of AS Thc cclls were used fresh or were stored in liquid nitro^en until use
Modified B27 AS eclis were obtained by mcubatinj, cclls with tht. euiture
fiitrate K4^ (obtained from Α Γ Geczy) aecording to thc protoeol desenbed in
Materials and Mcthods by Gcczy et al [1 ] C ontrol teils were incubated with the
euiture hl träte 199
MIC Thc prolifcrative ac ivity of efrector cclls wis measured in MLC by m< u
bating 5 X 1 0 responder ecils with 5 x 1 0 irntliarcd stimuLitor cclls m 200/xl
of eulture medium in mit,runter platcs After 3 days of Intubation Η thymidine
was added ιηά 24 hr larer rht jncorporation wis measured
CJL The t;encration ot AS speeihe effector eclis and thc tcctmg for specifit
eytotoxic activity using the stand ml ccll mediatcd lympho>.ytotoxicity (CML)
assay have becn carncd out atcordin^, to the protoeol desenbed in Materials -ind
Mcthods by Geezy et a! [l]
Cll hnes In a limitm^, dilutton (LD) eulture systern CTL Jines werc ^encrated
Gradcd numbers of responder PBL (lO 5 -^ x ΗΓ) were stimuUted with \{Ϋ
irradiatcd PBL frorn an HLA tdtnticai AS dffecied sibhng m 200 μϊ of eulturt.
medium containmg intcrieukin 2 (1L 2) (40 units/ml) After 6 days of nuubaiion
two sample s of 50 μλ of thc ttlJ eulture of each wel! werc tested for spccific
tytotoxtcity against stimulator and another AS B27 target ccll in ihc CML
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assay The rcmamini; teils in individual wclls werc restimulited with K)"1 scimula
cor ccils in 100 μλ fresh medium Another strcening for cytotoxiuty was per
formet! dt day 12 Ibosc ccil eulturcs that were found to bc positive on both
target eclis wtre trinsierrtd into welk tontaining i ml of culture medium and
wtre rtstimulated with 10' stimuUtor teils at da>s 1 3 and 19 At days 15 22 and
24 1 ml of medium containing II 2 wis added Ccl! cultures with abundant
prohfcration were divuied Fhe CTL hnts were tested for AS speeihe B27 associ
ated cytotoxieity at diy 25 a^ainst ehe stimulitor cclls and agiinst two additiond
AS B27 and two AS B2"7 tarnet cdh at an effettor to target rano of 10 1
ithe number of tirgtt cclls was Α x 101)
RFSUI TS
Thccytotoxic ictiviti^s of etfector ctlls genciatui in ? i AS /AS HLA identKal
sibling rcspondcr/stimulator piirs within 10 familici md in thrtc AS /AS HI Α
class 1 identit il (B27 subtypc-muchi.d) class l l-nonidcnucal unrclatcd combi
nations (ste Tiblcs 1 and 2) were testtti in the CML assay In onc ί ILA idcncical
siblmg pair (both healthy B27 individuals) cHcctor teils were gentrated using
stimulitor ccils t h u wtre modiiicd with either a K h or Γ99 (control) culture
suptrnat nit f urthtr inorc cells from onc randomly selecttd heilthy B2"1 blood
donor v/cre sttmuiated with lutologous ecils either Κ β or Γ99 motlifted Cyto
toxiiity was mc isured after 6 days ot eultunng as well is after rcsnmulation oi
C fL on d ly I 4 o f t u l t u r e is destribcd m Tablcs I and 2
In cornbin itions ot HLA identieil siblings (AS AS ) the MLC wis ilv, lys
iound to bc net,itive (proliteration was oniy tested m the combinations fiom
Amsterdam) In nonc of the HLA itlcntical AS /AS sibling combinations did
the CML lssiy show spccifie lysis above that of the medium control of the
sttmulatoi or thiri! ρ irty AS Β }Ί tirgct teils C clls irom the samt responders
stimuhted agunst 1 ILA chss 1- anti tlass ί ΐ-mism itehed celis showed good
prolifer ition and elfcenvclv Ivsed (M)-60 r r ""'C r rele isc) stimulator target etlls
No speeiiie 1>SIS oi AS tirt,ct teils wis found in tht AS /AS combinations of
HLA tliss I - identitü unr t lucd individuals diffenng in tlass II antigens al
though all hui ι positive MLC Morcover in nonc of the CTL riiscd against
stimul xtor cells modified with b icten il culture hlrr ites was AS sp^tiht cytotox
ititj ilttettctl Reprcseni iti\e results of the expenments ire givcn in ligure 1
I ckolf ind Shaw {12} d t s t r ib td in 1 D eukure s\stcm \s α pnmir> in vitro
method to >,entrite HLA rtstrieted CTL specific tor minor hutoeompatibiiiti
iminor 11) intimens bc tween HLA identit il siblinys The possil iht; ot producint,
AS spccilit ( II in such in Ι Ο System u is tx immc 1 I r o m i o i r A S /AS siblmg
ΓΑΒΙ1 I ( clls used in Amsterilim foi the induction oi AS speeitic C TL
( nihin ! ι K L S ] )i I r L U I S
B 2 7 AS
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TABLE 2 Cells ustd in Leiden for the inducnon of AS specific CTL
Combinai
Rtspondtr cclls Snmulator cells
(r t ) (s t 1
HLA class I - a n d class I] idcnti




B27 AS AuLoloBmsdc r t I
Unrdatcd B27 AS in - I)
UnrclitcJ 1327 AS (» ')
B27 AS ALitologoiLS li t r t )
K43 miidificd Spccificsc K4 5modi(lcd
SpccLhc s c F99 moiUficd
Same s c Unrtlaitd B27 AS (» I)
i)> modifitd Unrtlattd B27 AS (» 2)
SptufLis t K 4 1 m ) l i l t l
Specific s t 1 9 ; modifitd
Unrdatcd 1 3 " AS (/ 1











All t-ir^cc cclK arc usctl wiihouc uiy irnto^cnic. stirnui^tion ίι L 6 <Jays PBL IÜLHI eil u CIIL pro to t )l usc I tay
O c t / y t t li {I i) as WLÜ as stimulitL f f r ^2 hr v. th pi tyrol i tma^Jut i f im
h The rcsponiicr ccll p o p u h n m v.is «.timulitt. 1 with ctUs from ehe I ILA ι lei tical Mblnif, <J )iu r m ) Uhc 1 with
t ithcr Κ ιΐ (modifyini, f icior) or U 9 (t t ^ t i v i t incrol s u p c r r u t i m l both t u l t u r t h l tnces t i m i In m OHL ol rlic
c r o s s r e ^ t v e organisms (SLC M a t c n a J w m l Mcchals Gccz) u dl i J J
T h e resj )ii ler teil p o p u U n o n hai bt-tn mo I hc 1 wich K 4 ^ as v.tll is w rh I 9 J an 1 ι SLII as snmuUi >r/iari,ct
teils
pairs Τ ccll hncs wert gencrated and cested for AS sptcific cytotoxicity Somc
CTL ltncs were cytocoxic j-Or stimulacor targtt ceils somc third party AS B2*
7
as well as AS B27 target cells Othtr Τ ctli lmti> iysed somc chird party tirgct
cclls but were not rcactivt with the spetihe stimui itor cells Nonc ot the ccll lincs
were ablc to disnnguish AS from AS tirgct cclls
DISCUSSION
Our expenments cirncei out in ι stmitar way to thosc ofGcczy et al [1] did not
producc the same rcsalts Duc to vanations between Jabonronts jr is difhcult to
iisccrtain whetber the techniques employcd were rcaliy tdentical Howevi r wc
are not aware of important tethnical differenees that might aecount for the ob
served discrepancics On ehe otlicr iiand ehe paticnt (and control) stl<^tion eould
play a role In the work ofGcczy the positive rcsults emerged irom two HI Α
identica! AS /AS sibiing purs wc have examintd 21 such combinations (sec
Tablcs 1 and 2) without iinding t smgic positive tombination Aithough rhcic
may bc some dificrenecs in the paticnti examincl it is difncult to aeeept such a
cnticai degrec of discrepancy in the elmical dugnosis of the diseasc In fact the
latter cxplanation for discrepancy can be exeluded due to the pre^ence of the
seroiogically detcctable Geczy factor on the ceils of Durch AS patients in
previous blind Workshops [10 l l j Morcovcr in our expenments no CTL activ
lty WJS measured in the eultures with K43 modified stimulator cells
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by specifically raised tffector cells in HLA ciass I~ and class II-mismatched
combinations However in our expcnmental assay the oiseast and/or B27
associatcd strucrure apparently is not anngtnic cnough for AS spetifk CTL
inducnon
In conclusion for reasons which are not clcar to us we have not becri abic to
induce AS specifk CTL by MLC of B27 AS and B27 + AS+ cells or by B27 AS
cells modified with K43 supernatant culturc fiitrate The possibic modiücatton
of MHC anttgens on cells with the DR2/DQ1 haplotypc of paticnts with narco
icpsy has becn studied m a sjmilar geneticai set up by Strohmaier et al [13]
Narcoltpsy is the diseasc with the strongest HLA dssociauon nearly 100% of the
panents arc DR2/DQ1 ·" It was reported that no disease related alttration of
DR2 and DQl molccules on cells of narcolcpsy patients couid bc deteeeed by
normal Τ iymphocytcs
Funher expenmems may eiucidart wherber djscasc specific struetures do exist
on lymphocytes of paticnts with HLA associatcd discases and if so which of
the variables are umquely cntical for the activation of disease specific Τ lympho
Cytes
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